Authors: Burtness, B Belker, M Stoltz, M Peccerillo, KM Lamb, LA Chmael, SE McKeon, A Clark, MB Winship, J Marsh, JC Pizzorno, G DeVita, VT

Citation: B. Burtness et al., A phase I study of the antimetabolite (E)-2 '-fluoromethylene-2 '-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion, CANCER J, 6(5), 2000, pp. 309-315